Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
613.56
500.22
369.62
294.35
251.10
181.27
145.57
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
613.56
500.22
369.62
294.35
251.10
181.27
145.57
Raw Material Cost
104.72
81.40
50.74
36.54
34.61
24.31
17.79
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
172.65
147.03
127.05
128.93
135.52
74.21
29.15
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.50
0.53
0.46
0.14
0.17
0.04
0.04
Selling and Distribution Expenses
193.39
151.80
129.09
122.65
129.40
83.17
47.25
Other Expenses
-4.48
-1.34
-3.74
-7.63
-7.92
-4.79
-1.66
Total Expenditure (Excl Depreciation)
427.40
367.38
269.90
212.00
220.47
133.86
77.63
Operating Profit (PBDIT) excl Other Income
186.20000000000002
132.79999999999998
99.7
82.4
30.6
47.400000000000006
67.9
Other Income
22.81
20.05
20.85
23.92
18.84
18.99
5.36
Operating Profit (PBDIT)
252.50
175.96
133.70
112.75
56.36
71.66
78.79
Interest
1.50
0.53
0.46
0.14
0.17
0.04
0.04
Exceptional Items
0.83
0.74
1.00
0.89
0.97
0.34
0.00
Gross Profit (PBDT)
508.84
418.81
318.88
257.81
216.49
156.96
127.78
Depreciation
45.71
25.39
14.23
7.36
7.39
5.67
5.81
Profit Before Tax
206.13
150.79
120.02
106.14
49.76
66.29
72.95
Tax
26.45
18.64
10.61
11.74
-1.51
10.37
10.06
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
193.57
146.33
115.21
95.13
51.20
56.53
63.08
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
193.57
146.33
115.21
95.13
51.20
56.53
63.08
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-13.89
-14.19
-5.80
-0.73
0.06
-0.61
-0.20
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
179.68
132.14
109.41
94.39
51.26
55.92
62.89
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,326.92
1,252.60
1,194.61
1,101.45
989.51
837.34
765.68
Earnings per share (EPS)
1.41
1.06
0.84
0.7
0.38
0.42
0.47
Diluted Earnings per share
1.41
1.06
0.84
0.7
0.38
0.42
0.47
Operating Profit Margin (Excl OI)
29.99%
26.09%
26.68%
27.68%
12.0%
25.93%
46.45%
Gross Profit Margin
41.05%
35.22%
36.32%
38.56%
22.76%
39.7%
54.1%
PAT Margin
31.55%
29.25%
31.17%
32.32%
20.39%
31.18%
43.34%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 22.67% vs 35.34% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 36.03% vs 20.75% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 47.34% vs 38.09% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 200.00% vs 0.00% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Beijing Balance Medical Technology Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
613.56
0
613.56
Other Operating Income
0.00
0.00
0.00
Total Operating income
613.56
0
613.56
Raw Material Cost
104.72
0
104.72
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
172.65
0
172.65
Power Cost
0
0
0.00
Manufacturing Expenses
1.50
0
1.50
Selling and Distribution Expenses
193.39
0
193.39
Other Expenses
-4.48
0.00
-4.48
Total Expenditure (Excl Depreciation)
427.40
0
427.40
Operating Profit (PBDIT) excl Other Income
186.15
0.00
186.15
Other Income
22.81
0
22.81
Operating Profit (PBDIT)
252.50
0
252.50
Interest
1.50
0
1.50
Exceptional Items
0.83
0
0.83
Gross Profit (PBDT)
508.84
0
508.84
Depreciation
45.71
0
45.71
Profit Before Tax
206.13
0
206.13
Tax
26.45
0
26.45
Provisions and contingencies
0
0
0.00
Profit After Tax
193.57
0
193.57
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
193.57
0
193.57
Share in Profit of Associates
0
0
0.00
Minority Interest
-13.89
0
-13.89
Other related items
0.00
0.00
0.00
Consolidated Net Profit
179.68
0
179.68
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,326.92
0
1,326.92
Earnings per share (EPS)
1.41
0
1.41
Diluted Earnings per share
1.41
0
1.41
Operating Profit Margin (Excl OI)
29.99%
0%
0.00
29.99%
Gross Profit Margin
41.05%
0%
0.00
41.05%
PAT Margin
31.55%
0%
0.00
31.55%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 61.36 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 22.67% vs 35.34% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 17.97 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 36.03% vs 20.75% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 22.97 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 47.34% vs 38.09% in Dec 2024
Annual - Interest
Interest 0.15 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 200.00% vs 0.00% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 29.99%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024






